Biomimetic “Nanoplatelets” as a Targeted Drug Delivery Platform for Breast Cancer Theranostics-Reference-Cited by-同舟云学术

Biomimetic “Nanoplatelets” as a Targeted Drug Delivery Platform for Breast Cancer Theranostics

Published:2021-01-15 Issue:3 Volume:13 Page:3605-3621
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Li Lin¹,Fu Jian²,Wang Xingyue¹,Chen Qiaoqi¹,Zhang Wei¹,Cao Yang¹,Ran Haitao¹^ORCID

Affiliation:

1. Chongqing Key Laboratory of Ultrasound Molecular Imaging, Ultrasound Department of the Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P. R. China

2. Vascular Surgery Department of the Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P. R. China

Funder

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Chongqing Postdoctoral Program for Innovative Talents

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.0c19259

Reference41 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Differential prognostic relevance of patho-anatomical factors among different tumor-biological subsets of breast cancer: Results from the adjuvant SUCCESS A study

3. Factors associated with time to first healthcare visit, diagnosis and treatment, and their impact on survival among breast cancer patients in Mali

4. Breast cancer survival in Ethiopia: A cohort study of 1,070 women

5. Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomimetic Cell Membrane‐Coated Nanoparticles for Cancer Theranostics;ChemMedChem;2024-09-12

2. From bench to bedside: Platelet biomimetic nanoparticles as a promising carriers for personalized drug delivery;Journal of Controlled Release;2024-09

3. Cuproptosis engineered nanomaterials: The silent warrior against cancer;Applied Materials Today;2024-08

4. Recent Advancement of Nanotheranostics in Cancer Applications;Current Drug Delivery;2024-05-29

5. Three musketeers of PDA-based MRI contrasting and therapy;Artificial Cells, Nanomedicine, and Biotechnology;2024-05-25